Elizabeth E. Reed is CLO at Travere Therapeutics, Inc. (TVTX). They have made 15 open-market trades across 2 companies since 2006, most recently 2026-09-15.
CIK 0001283303
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 15 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| TVTX | 105,389 | $5.2M |
| RTRX | 25,431 | $616K |
| ANDS | 1,537 | — |
| Total | $5.8M |
Shares reported on the most recent Form 4, priced at the 2026-09-17 close. 1 holding could not be priced and is excluded from the total.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TVTX | SELL · 10b5-1 | 2026-09-15 | 2026-09-17 | $62.34 | $2.3M | -7.0% | — | — |
| TVTX | SELL · 10b5-1 | 2026-05-04 | 2026-05-06 | $45.06 | $1.1M | -5.7% | +0.6% | +23.2% |
| TVTX | SELL · 10b5-1 | 2026-04-14 | 2026-04-15 | $41.29 | $2.1M | +2.5% | +6.9% | +43.3% |
| TVTX | SELL · 10b5-1 | 2026-04-01 | 2026-04-02 | $30.00 | $300K | +33.5% | +46.5% | +83.7% |
| TVTX | SELL · 10b5-1 | 2026-03-16 | 2026-03-18 | $28.09 | $562K | +3.4% | +52.5% | +99.4% |
| TVTX | SELL | 2026-02-17 | 2026-02-19 | $27.83 | $278K | -4.1% | -5.9% | +47.5% |
| TVTX | SELL · 10b5-1 | 2026-02-04 | 2026-02-05 | $32.18 | $96K | -6.8% | -3.1% | +49.6% |
| TVTX | SELL | 2026-02-03 | 2026-02-03 | $32.12 | $230K | -15.2% | -16.7% | +37.0% |
| TVTX | SELL | 2026-01-20 | 2026-01-21 | $27.34 | $273K | +17.4% | +7.8% | +37.5% |
| TVTX | SELL · 10b5-1 | 2025-09-22 | 2025-09-24 | $25.00 | $250K | +7.0% | +14.9% | +44.8% |
| TVTX | SELL · 10b5-1 | 2025-05-05 | 2025-05-05 | $21.05 | $104K | +0.7% | -27.6% | -24.0% |
| TVTX | SELL · 10b5-1 | 2025-02-12 | 2025-02-12 | $23.53 | $188K | -10.5% | -14.4% | -9.2% |
| TVTX | SELL · 10b5-1 | 2025-02-03 | 2025-02-04 | $19.78 | $354K | +8.8% | -10.1% | +1.7% |
| TVTX | SELL · 10b5-1 | 2025-01-22 | 2025-01-23 | $19.46 | $47K | +0.7% | +1.3% | -20.3% |
| TVTX | SELL · 10b5-1 | 2024-09-09 | 2024-09-09 | $11.52 | $101K | +16.7% | +36.4% | +45.5% |
| TVTX | SELL · 10b5-1 | 2024-02-01 | 2024-02-02 | $8.71 | $41K | -0.8% | -1.6% | -26.0% |
| TVTX | SELL · 10b5-1 | 2024-01-23 | 2024-01-25 | $8.96 | $18K | -5.5% | -12.5% | -40.6% |
| TVTX | SELL · 10b5-1 | 2023-09-05 | 2023-09-05 | $14.71 | $27K | -4.1% | -44.7% | -56.0% |
| TVTX | SELL · 10b5-1 | 2023-05-10 | 2023-05-12 | $16.59 | $14K | +6.1% | +8.4% | -0.8% |
| TVTX | SELL | 2023-02-01 | 2023-02-02 | $22.25 | $115K | -7.8% | +0.7% | -28.0% |
| TVTX | SELL · 10b5-1 | 2023-01-24 | 2023-01-26 | $21.50 | $44K | -0.2% | -0.5% | -5.6% |
| TVTX | SELL · 10b5-1 | 2022-05-10 | 2022-05-12 | $21.51 | $42K | +1.5% | +6.1% | +29.1% |
| TVTX | SELL · 10b5-1 | 2022-01-31 | 2022-02-02 | $27.40 | $37K | +9.3% | +2.7% | +0.3% |
| TVTX | SELL | 2022-01-24 | 2022-01-26 | $24.98 | $56K | +4.5% | +0.8% | -0.4% |
| TVTX | SELL | 2022-01-11 | 2022-01-12 | $27.40 | $137K | -0.0% | +5.7% | +8.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.